US Stock MarketDetailed Quotes

Edesa Biotech (EDSA)

Watchlist
  • 5.930
  • +0.790+15.37%
Close Apr 17 16:00 ET
  • 5.910
  • -0.020-0.34%
Post 19:08 ET
52.69MMarket Cap-5.54P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Edesa Biotech (EDSA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-37.58%-2.09M
-49.73%-7.32M
-77.97%-1.72M
-98.58%-1.7M
-43.56%-2.38M
-7.87%-1.52M
26.31%-4.89M
34.13%-967.04K
52.56%-856.48K
-5.60%-1.66M
Net income from continuing operations
-38.98%-2.25M
-16.46%-7.19M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
Operating gains losses
----
----
----
----
----
----
----
----
--0
----
Depreciation and amortization
-40.94%25.46K
-35.89%119.27K
-41.48%25.87K
-49.85%25.79K
-46.01%24.51K
-4.27%43.11K
1.41%186.05K
-3.84%44.21K
-38.05%51.42K
66.26%45.4K
Other non cash items
----
----
----
----
----
----
---14.77K
--0
----
----
Change In working capital
-993.09%-264.99K
-272.60%-985.65K
153.85%77.07K
-123.74%-154.47K
-4,340.88%-884.01K
-156.99%-24.24K
85.41%571.07K
53.94%-143.13K
5,772.55%650.81K
-95.34%20.85K
-Change in receivables
322.52%217.39K
-206.08%-377.99K
-226.33%-359.83K
-80.13%110.4K
91.97%-30.87K
1.90%-97.69K
-36.68%356.34K
148.58%284.84K
4,818.65%555.61K
-596.45%-384.53K
-Change in prepaid assets
-457.32%-155.92K
-45.30%107.83K
-60.59%34.48K
97.37%-3.37K
-83.40%33.09K
12.86%43.64K
-34.62%197.14K
333.14%87.49K
-164.75%-128.32K
139.75%199.3K
-Change in payables and accrued expense
-1,194.96%-326.45K
-4,167.65%-715.5K
178.07%402.42K
-216.99%-261.5K
-530.07%-886.23K
-71.18%29.81K
103.16%17.59K
-264.60%-515.45K
201.16%223.52K
-28.14%206.07K
Cash from discontinued investing activities
Operating cash flow
-37.58%-2.09M
-49.73%-7.32M
-77.97%-1.72M
-98.58%-1.7M
-43.56%-2.38M
-7.87%-1.52M
26.31%-4.89M
34.13%-967.04K
52.56%-856.48K
-5.60%-1.66M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
61.98%3.36M
2,776.69%17.03M
693.23%186.48K
0
6,878.24%14.77M
577.55%2.07M
-87.74%592.03K
-107.62%-31.44K
-85.70%106.03K
-72.31%211.7K
Net issuance payments of debt
----
--0
--0
--0
----
----
---29.53K
--0
--0
----
Net common stock issuance
458.08%3.5M
958.10%7.72M
--220.5K
--0
2,391.39%6.87M
98.84%626.76K
-83.21%729.39K
--0
-83.40%138.42K
--275.77K
Net preferred stock issuance
--0
--9.88M
--0
--0
--8.34M
--1.54M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
----
---23.45K
--0
--0
----
----
--0
--0
--0
----
Net other financing activities
-48.29%-142.41K
-404.63%-544.11K
-8.22%-34.02K
--0
-1,098.98%-414.06K
-915.28%-96.04K
62.23%-107.82K
55.92%-31.44K
64.98%-32.4K
-486.22%-34.53K
Cash from discontinued financing activities
Financing cash flow
61.98%3.36M
2,776.69%17.03M
693.23%186.48K
--0
6,878.24%14.77M
577.55%2.07M
-87.74%592.03K
-107.62%-31.44K
-85.70%106.03K
-72.31%211.7K
Net cash flow
Beginning cash position
940.39%10.79M
-80.65%1.04M
505.70%12.36M
396.37%13.9M
-63.37%1.56M
-80.65%1.04M
-24.39%5.36M
-68.39%2.04M
-62.53%2.8M
-48.40%4.27M
Current changes in cash
128.75%1.27M
325.88%9.71M
-53.69%-1.53M
-126.63%-1.7M
955.36%12.39M
150.36%554.34K
-137.95%-4.3M
5.41%-998.47K
29.47%-750.45K
-79.37%-1.45M
Effect of exchange rate changes
69.78%-8.51K
278.42%46.22K
-587.76%-35.01K
2,099.36%165.81K
-186.47%-56.42K
-492.42%-28.16K
-133.71%-25.9K
87.34%-5.09K
-116.62%-8.29K
-330.36%-19.7K
End cash Position
670.82%12.05M
940.39%10.79M
940.39%10.79M
505.70%12.36M
396.37%13.9M
-63.37%1.56M
-80.65%1.04M
-80.65%1.04M
-68.39%2.04M
-62.53%2.8M
Free cash flow
-37.58%-2.09M
-49.73%-7.32M
-77.97%-1.72M
-98.58%-1.7M
-43.56%-2.38M
-7.87%-1.52M
26.31%-4.89M
34.13%-967.04K
52.56%-856.48K
-5.60%-1.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -37.58%-2.09M-49.73%-7.32M-77.97%-1.72M-98.58%-1.7M-43.56%-2.38M-7.87%-1.52M26.31%-4.89M34.13%-967.04K52.56%-856.48K-5.60%-1.66M
Net income from continuing operations -38.98%-2.25M-16.46%-7.19M-131.63%-2.23M-4.87%-1.75M14.55%-1.59M3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M
Operating gains losses ----------------------------------0----
Depreciation and amortization -40.94%25.46K-35.89%119.27K-41.48%25.87K-49.85%25.79K-46.01%24.51K-4.27%43.11K1.41%186.05K-3.84%44.21K-38.05%51.42K66.26%45.4K
Other non cash items ---------------------------14.77K--0--------
Change In working capital -993.09%-264.99K-272.60%-985.65K153.85%77.07K-123.74%-154.47K-4,340.88%-884.01K-156.99%-24.24K85.41%571.07K53.94%-143.13K5,772.55%650.81K-95.34%20.85K
-Change in receivables 322.52%217.39K-206.08%-377.99K-226.33%-359.83K-80.13%110.4K91.97%-30.87K1.90%-97.69K-36.68%356.34K148.58%284.84K4,818.65%555.61K-596.45%-384.53K
-Change in prepaid assets -457.32%-155.92K-45.30%107.83K-60.59%34.48K97.37%-3.37K-83.40%33.09K12.86%43.64K-34.62%197.14K333.14%87.49K-164.75%-128.32K139.75%199.3K
-Change in payables and accrued expense -1,194.96%-326.45K-4,167.65%-715.5K178.07%402.42K-216.99%-261.5K-530.07%-886.23K-71.18%29.81K103.16%17.59K-264.60%-515.45K201.16%223.52K-28.14%206.07K
Cash from discontinued investing activities
Operating cash flow -37.58%-2.09M-49.73%-7.32M-77.97%-1.72M-98.58%-1.7M-43.56%-2.38M-7.87%-1.52M26.31%-4.89M34.13%-967.04K52.56%-856.48K-5.60%-1.66M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 61.98%3.36M2,776.69%17.03M693.23%186.48K06,878.24%14.77M577.55%2.07M-87.74%592.03K-107.62%-31.44K-85.70%106.03K-72.31%211.7K
Net issuance payments of debt ------0--0--0-----------29.53K--0--0----
Net common stock issuance 458.08%3.5M958.10%7.72M--220.5K--02,391.39%6.87M98.84%626.76K-83.21%729.39K--0-83.40%138.42K--275.77K
Net preferred stock issuance --0--9.88M--0--0--8.34M--1.54M--0--0--0--0
Proceeds from stock option exercised by employees -------23.45K--0--0----------0--0--0----
Net other financing activities -48.29%-142.41K-404.63%-544.11K-8.22%-34.02K--0-1,098.98%-414.06K-915.28%-96.04K62.23%-107.82K55.92%-31.44K64.98%-32.4K-486.22%-34.53K
Cash from discontinued financing activities
Financing cash flow 61.98%3.36M2,776.69%17.03M693.23%186.48K--06,878.24%14.77M577.55%2.07M-87.74%592.03K-107.62%-31.44K-85.70%106.03K-72.31%211.7K
Net cash flow
Beginning cash position 940.39%10.79M-80.65%1.04M505.70%12.36M396.37%13.9M-63.37%1.56M-80.65%1.04M-24.39%5.36M-68.39%2.04M-62.53%2.8M-48.40%4.27M
Current changes in cash 128.75%1.27M325.88%9.71M-53.69%-1.53M-126.63%-1.7M955.36%12.39M150.36%554.34K-137.95%-4.3M5.41%-998.47K29.47%-750.45K-79.37%-1.45M
Effect of exchange rate changes 69.78%-8.51K278.42%46.22K-587.76%-35.01K2,099.36%165.81K-186.47%-56.42K-492.42%-28.16K-133.71%-25.9K87.34%-5.09K-116.62%-8.29K-330.36%-19.7K
End cash Position 670.82%12.05M940.39%10.79M940.39%10.79M505.70%12.36M396.37%13.9M-63.37%1.56M-80.65%1.04M-80.65%1.04M-68.39%2.04M-62.53%2.8M
Free cash flow -37.58%-2.09M-49.73%-7.32M-77.97%-1.72M-98.58%-1.7M-43.56%-2.38M-7.87%-1.52M26.31%-4.89M34.13%-967.04K52.56%-856.48K-5.60%-1.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -